Anzeige
Meldung des Tages: Freitagabend nachbörslich veröffentlicht – was der Markt erst am Montag sieht

Zum US-Depot für ESKIVANA.


Beiträge: 71
Zugriffe: 20.626 / Heute: 5
SORRENTO NET.
kein aktueller Kurs verfügbar
 
L3 Harris Techno. 289,10 € +0,00%
Perf. seit Threadbeginn:   +1795,74%
 
S&P 500 6.941,02 -0,33%
Perf. seit Threadbeginn:   +375,74%
Eskimato:

Zum US-Depot für ESKIVANA.

 
03.01.04 20:05
Ich gehe jetzt davon aus, dass diesem Teil des Gesamtdepots 40000 Euros zur Verfügung stehen. Es gibt scheinbar den Wunsch, dass Anfangsvolumen für die Zertis etwas hochzufahren, bei dem was f.h. konzeptionell heute vorgestellt hat sehr verständlich.

Diese 40000 Euros möchte ich mit Eurer Hilfe zu 75% in den vielen hervorragenden Investmentvorschlägen anlegen und zu 25% für Swingtrading einsetzen.

Ich spreche von Euro, weil wir als GbR keinen direkten Account in den USA haben, sondern immer auf Euro-Basis kaufen werden. Kaufen werden wir schon direkt an den amerikanischen Börsenplätzen über E-Trade, dargestellt wird das Depot allerdings dann in Euro.

Ergo stehen 30000 Euro für langfristige Anlagen bereit, 10000 Euro für Swingtrades.

Bei dem langfristigen Teil stelle ich mir 10 Postionen a 3000 Euro vor, wobei wir immer
5 verschiedenen Themen abdecken sollten.

Es gibt seit IVAN und dem Stomausfall in New York natürlich das Energiethema. Dazu hat
Patzi drei nette Vorschläge gemacht, ich würde da auch derzeit ROYL oder Turkcell mit in die Diskussion bringen. Zu Headwaters gibt es einen eigenen Thread von mir aus Mitte 2002, nur ARIVA speichert den Thread nicht so lange, wenn man ihn nicht rechtzeitig vorm Verfall hochholt.

Das zweite Thema sind chinesische respektive asiatische Shares. Da gibt es Überschneidungen zum ersten Thema, mit JCC und BYH hätten wir zwei Shares, die auch dem ersten Thema gerecht werden und tolle Quartalszahlen abgeliefert haben.
Interessant find ich auch GCH, als so eine Dachfondsaktie für chinesische Shares. Auch das IPO LFC ist hochinteressant.

Das dritte Thema sind die Nanos seit dem Programm, dass die George Bush-Administration aufgelegt hat. An TINY, ALTI, USGA oder NGEN kommen wir derzeit kaum vorbei.

Das vierte Thema sind die Communication-Shares. Da fangen wir einfach mit EONC an und nehmen noch aus den Emerging Markets HANA oder MTE hinzu.
zick-zocks/paracorps PRTL ist natürlich auch einen Blick wert. Im US-Wettbewerb 2003 zu 1,70 eingeführt, jetzt schon über 11 Dollar.

Das fünfte Thema sind die Minenaktien. Kein langfristiges Depot ohne eine Goldmine, oder? Mit BGO oder RGLD kann man kaum etwas verkehrt machen.
Der kleine Explorer SNRN als spekulative Beilage von der OTC gefällt mir gut.

Das sechste Thema sind die Sportbekleider. In Deutschland kennt und schätzt jeder den Chart von PUMA oder Adidas.
In den USA hatte ich mich fast mit Grueni auf DECK geeinigt, aber auch eine COLM, URBN oder Tommy Holfinger gefallen mir als Langfristanlage.

Das siebte Thema sind die Halbleiter, das achte Thema die Stahlaktien, das neunte Thema die Networker, das zehnte Thema die Gesundheitsshares, das elfte Thema die Bios, das zwölfte Thema die Gamingaktien, das dreizehnte Thema die Finanzdienstleister und Banken, es sind längst nicht alle Themen.
Doch die ersten fünf Themen möchte ich zunächst favorisieren, für die restlichen Themen schiebt uns die Zertifraktion die Gewinne irgenwann rüber um dort langfristige Engagements einzugehen.

Bleiben noch die 10000 Euro für Swingtrading. Da gibt es täglich Chancen, wo ich oder andere von uns mal eine überverkaufte Situation oder einen potentiellen Hype sehen.
Da unterhält man sich dann über Commerce One, ORCH, SIRI oder CYPT von mir aus. Meine DMED aus der letzten Runde des US-Wettbewerbs haben Freitag 39% zugelegt, Zockershares kennen wir wahrlich genug.
Und die vielen tollen Shares, die im Prinzip gut laufen, wo sich aber eine nette Einstiegsgelegenheit ergibt. Da kennen wir ja nun auch reichlich Shares.
In Frage kommen Shares wir IRSN, TGAL, ASVI, CALM, ACET, AMHC, NTES, HRT, BSMD, BCSI, BLTI, MOBI, OPSW, LPSN, CYAN, GIVN, GTI, EVOL, GEMS, TUTS, TTMI ORCT, VIP. FSTW läuft grad wieder an, etc. etc. Diese Liste würde den Rahmen sprengen, sonst stehen hier 500 Kürzel.
Aber auch bei den Swingtradeshares, für die 10000 Euro zur Verfügung stehen, sollen es immer vier verschiedene Shares. Da suchen wir uns immer was Nettes raus und halten wohl nicht lange.

In dieser grundsätzlichen Anfangsphase möchte ich lieber über die Themen diskutieren und die angedachte Aufteilung zwischen Fest-und Swingtrading, ob Ihr eine andere Gewichtung favorisieren würdet, nicht so sehr die Einzelwerte.
In keinem Fall möchte ich ein überlastetes Themendepot beginnen, eine breite Streuung in viele Themen wäre mir lieber.

Gruss E.

Antworten

Werbung

Entdecke die beliebtesten ETFs von SPDR


r4lle:

Klasse Beitrag Eski

 
03.01.04 20:17
da zieh ich meinen Hut !!! RESPEKT
Falls du einen jeweiligen Chart benötigst, sag bescheid.

 

greetz

Antworten
Eskimato:

Freiwillige Helfer gesucht für das US-Research.

 
03.01.04 21:10

Aufgabe Nummer ist das Lesen und das Veröffentlichen der Zacks-Kolumne. Diese tägliche
Buy and Sell-Kolumne findet man auf der Startseite von freerealtime.com.
Wenn sich dort ein paar von uns abwechselnd reinlesen und hier reinkopieren, wäre das hilfreich.
Diese Kolumne bewegt viel, am 26.12. hatten die Zacks Leute z.B. NGEN empfohlen, danch in 3 Tagen von 7 auf über 12 Dollar gelaufen.
Ein tägliches Hereinkopieren wäre eine tolle Fleissaufgabe, die man sich in Absprache teilen könnte.

Gruss E.

So könnte es täglich aussehen:

 

Zacks Buy List Highlights: -- Jan 2 2004

CHICAGO, Jan 2, 2004 (BUSINESS WIRE) -- Zacks.com releases another list of stocks that are currently members of the coveted Zacks #1 Ranked list which has produced an average annual return of +33.7% since inception in 1988 and has gained +100.3% since January 2000 when the market was in the grips of the worst bear market in 60 years. Among the #1 ranked stocks today we highlight the following companies: aaiPharma Inc. (NASDAQ:AAII) and Lawson Software, Inc. (NASDAQ:LWSN). Further they announced #2 Rankings (Buy) on two other widely held stocks: Apple (NASDAQ:AAPL) and eResearch Technology, Inc. (NASDAQ:ERES). To see the full Zacks #1 Ranked list or the rank for any other stock then visit. http://at.zacks.com/?id=88

Here is a synopsis of why these stocks have a Zacks Rank of 1 (Strong Buy). Note that a #1 Strong Buy rating is applied to 5% of all the stocks we rank:

aaiPharma Inc. (NASDAQ:AAII) is a science-based specialty pharmaceutical company with more than 24 years of drug development experience. Focusing on targeted therapeutic areas, AAII markets a growing portfolio of established branded products and applies innovative technologies to increase the commercial potential of these products. Based upon the company's current business performance and the overall outlook for 2004, aaiPharma expects net revenue for 2004 to be in the range of $340 million to $355 million and earnings to be in the range of $1.45 to $1.52 per diluted share. AaiPharma recently completed the acquisition of four C-II pain products and the launch and marketing promotion of these products are planned to begin in the first quarter of 2004. These products are expected to make a positive impact on the company's bottom line. After beating the third quarter's estimates by +72%, AAII looks poised to finish 2003 strongly. Over the past 30 days, analysts have raised this year's estimate by 2 cents and next year's by a full 13 cents or +10.2%. The strong pipeline has many analysts positive on the company and it might be worth a second look.

Lawson Software, Inc. (NASDAQ:LWSN) provides business process software solutions that help services organizations in the healthcare, retail, professional services, public sector, financial services, and other strategic markets achieve competitive advantage. Earlier this month Lawson reported revenues of $84.3 million for its fiscal 2004 second quarter ended Nov. 30, 2003. License fee revenues were slightly lower at $17.3 million in the second quarter, compared with $19.0 million in the fiscal 2003 second quarter. The company posted pro forma net income of $656,000, or 1 cent per diluted share, compared with the Street's estimate of a 3-cent loss. Improved pipeline execution combined with the restructuring actions and operating efficiency improvements have strengthened the overall health of their business in this fiscal year. The company signed 135 deals and 16 new customers in the quarter at an average selling price of $445,000, compared with 32 new customers at an average selling price of $319,000 in the second quarter of fiscal 2003. After beating the Street's estimates last quarter by +133%, analysts have raised this year's EPS estimates by a whopping +50% over the past 30 days. Things look to be headed in the right direction and LWSN could be the investment solution investors are looking for heading into 2004.

Here is a synopsis of why these stocks have a Zacks Rank of 2 (Buy). Note that a #2 Buy rating is applied to 15% of all the stocks we rank:

Apple (NASDAQ:AAPL) designs, manufactures and markets personal computers and related personal computing and communicating solutions for sale primarily to education, creative, consumer, and business customers. In October, Apple announced financial results for its fiscal 2003 fourth quarter ended September 27, 2003. For the quarter, the company posted a net profit of $44 million, or 12 cents per diluted share. This compares to a net loss of ($45 million), or (13 cents) per diluted share, in the year-ago quarter. Revenues for the quarter were $1.715 billion, up +19% from the year-ago quarter. Apple shipped 787 thousand Macintosh units during the quarter, up +7% from the year-ago quarter, as well as 336 thousand iPod units, up a remarkable +140% from the year-ago quarter. Apple's balance sheet remains strong and their working capital management is among the best in the industry. Looking ahead to the first quarter of fiscal 2004, the company expects a sequential increase in revenues to about $1.9 billion and a slight sequential increase in GAAP earnings relative to the September quarter. For the year, the company reported net income of $69 million on revenues of $6.21 billion compared to net income of $65 million on revenues of $5.74 billion in 2002. With new innovative products continually coming down the road, this company could be the apple of an investor's eye.

eResearch Technology, Inc. (NASDAQ:ERES) is a provider of integrated software applications and technology consulting services to the pharmaceutical, biotechnology and medical device industries. Last month, eResearch Technology announced that it is confident in its ability to meet or exceed its current guidance for the rest of 2003 and 2004. ERES expects to report fourth quarter revenues for the quarter ended December 31, 2003 of $18.7 to $19.0 million and earnings of 19 cents to 20 cents per diluted share. For the full year of 2003, it expects revenues of $64.5 to $64.8 million and expects diluted earnings per share of 57 cents to 58 cents. In 2004, ERES expects to report revenues of $99 to $101 million and earnings of $1.02 to $1.05 per diluted share. ERES reported solid third quarter results in October, including net income of 16 cents per diluted share that was almost +200% better than last year (split-adjusted) while 2 cents, or more than +14%, ahead of the consensus. Furthermore, revenues of $17.5 million in the quarter were +60% better than last year and +18% better than the previous quarter. The company has managed over the past 4 quarters to beat Wall Street's expectation by about +21%. Research said that it continues to see growing momentum in its commercial business, and have had active discussions with both large and mid-tier pharmaceutical companies that are seeking to secure committed ECG capacity through "Franchise" agreements. eResearch appears to be on the right course heading into the future and may help to add some first aid to your portfolio.

Antworten
Eskimato:

Freiwillige Helfer gesucht, Teil 2.

 
03.01.04 21:18

Interessant ist ebenfalls die Kolumne Movers and Shakers von CBS. Es wäre schön, wenn sich auch hier Freiwillige finden, sich dort anmelden und die Kolumne regelmässig veröffentlichen.

Gruss E.

So könnte es aussehen:

MOVERS & SHAKERSZum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421
Sonic Corp., Walgreen, Ciphergen
By Tomi Kilgore, CBS.MarketWatch.com
Last Update: 8:34 PM ET Jan. 2, 2004
Zum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421

Among the companies whose shares are expected to see active trading in Monday's session is Sonic Corp. (SONC: news, chart, profile). The largest operator of fast-food drive-in restaurants in the U.S. is expected to show a profit of 30 cents a share for its fiscal first-quarter, according to analysts polled by Thomson First Call.

var ShockMode = 0;var plugin = (navigator.mimeTypes && navigator.mimeTypes["application/x-shockwave-flash"]) ? navigator.mimeTypes["application/x-shockwave-flash"].enabledPlugi­n : 0;if (plugin &&parseInt(plugin.description.substring(plugin.description.indexOf(".")-1)) >=4) {  ShockMode = 1;}else if (navigator.userAgent &&navigator.userAgent.indexOf("MSIE")>=0    && (navigator.userAgent.indexOf("Windows 95")>=0 ||    navigator.userAgent.indexOf("Windows 98")>=0 ||    navigator.userAgent.indexOf("Windows NT")>=0)){  document.write('');  document.writeln('  on error resume next ');  document.write('  ShockMode = (IsObject(CreateObject("ShockwaveFlash.ShockwaveFlash.4")))');  document.write('');}if ( ShockMode ){document.write("     ");}else if (!(navigator.appName&& navigator.appName.indexOf("Netscape")>=0 &&navigator.appVersion.indexOf("2.")>=0)) {  document.write('Zum US-Depot für ESKIVANA. 1323421');}  on error resume next   ShockMode = (IsObject(CreateObject("ShockwaveFlash.ShockwaveFlash.4")))     Zum US-Depot für ESKIVANA. 1323421
  CBS MARKETWATCH TOP NEWS
Wall Street returning in full force
Greenspan says Fed's cuts reduced shocks to economy
Beware the Double-D
Brighter U.S. jobs outlook seen as payroll data awaited
Stocks to watch Monday
Zum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421Free! Sign up here to receive our Weekly Roundup e-Newsletter!
 TRADING CENTER
Zum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421Zum US-Depot für ESKIVANA. 1323421Zum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421Zum US-Depot für ESKIVANA. 1323421Zum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421Zum US-Depot für ESKIVANA. 1323421Zum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421TRACK THESE TOPICSZum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421My PortfolioZum US-Depot für ESKIVANA. 1323421Zum US-Depot für ESKIVANA. 1323421AlertsZum US-Depot für ESKIVANA. 1323421
Company: Sonic CorpZum US-Depot für ESKIVANA. 1323421AddZum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421CreateZum US-Depot für ESKIVANA. 1323421
Column: Movers & ShakersZum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421CreateZum US-Depot für ESKIVANA. 1323421
Company: Walgreen Co.Zum US-Depot für ESKIVANA. 1323421AddZum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421CreateZum US-Depot für ESKIVANA. 1323421
Company: Boyd Bros Transportation IncZum US-Depot für ESKIVANA. 1323421AddZum US-Depot für ESKIVANA. 1323421
Zum US-Depot für ESKIVANA. 1323421CreateZum US-Depot für ESKIVANA. 1323421
Get Breaking News sent directly to your inbox
Zum US-Depot für ESKIVANA. 1323421
 Create A Portfolio | Create An Alert

The nation's largest drugstore chain, Walgreen (WAG: news, chart, profile) is seen posting earnings of 25 cents a share for the first quarter.

Friday's advancers

Shares of Boyd Bros. Transportation (BOYD: news, chart, profile) leapt almost 16 percent Friday after the trucking company said late Wednesday that it would go private. Under terms of the deal, BBT Acquisition Corp., a company controlled by Boyd's founder and its chief executive, will pay $7 in cash for each Boyd stock outstanding.

FreeMarkets (FMKT: news, chart, profile) hiked up nearly 16 percent after Summit Analytic Partners upgraded the stock to "long-term buy" from "long-term sell," saying the deal to buy Covisint was a "good one" for the company. The supply management software company said early Wednesday that it was buying Covisint, an electronic business services provider for the auto industry, for an undisclosed sum.

Hong Kong-based Highway Holdings (HIHO: news, chart, profile) ran up almost 44 percent after saying it received an order for lighting fixtures from a subsidiary of Germany's Siemens (SI: news, chart, profile) valued at $3.7 million. Production is expected to begin in March or April 2004, with the initial term expiring at the end of 2004. The order can be extended at one-year increments.

Friday's decliners

Shares of Ciphergen Biosystems (CIPH: news, chart, profile) tumbled more than 26 percent after the company warned that fourth-quarter revenue would fall short of prior projections due to disappointing sales of its ProteinChip System in the U.S. The proteomics research company now expects revenue of $15 to $15.5 million, vs. previous forecasts of $19 million. For all of 2003, revenue is expected to total $58.5 million, which is 50 percent above year-earlier levels.

Gundle/SLT Environmental shares (GSE: news, chart, profile) sank almost 13 percent after the geosynthetic lining maker agreed to be acquired by Code Hennessy & Simmons LLC at a discount to Wednesday's closing price. The stock was the biggest percentage loser on the NYSE. Under terms of the deal, each Gundle share will be converted into $18.50 in cash, which was 11 percent below Wednesday's closing price of $20.76.

Tomi Kilgore is a reporter for CBS.MarketWatch.com in New York.

 

 

Antworten
Eskimato:

Freiwillige Helfer gesucht, Teil 3.

 
03.01.04 21:54

Der aufwendigste Teil ist das Screenen des Marktes. Das ist eine gewaltige Fleissaufgabe, die sich aber mit Sicherheit lohnt.
Wie man dass anstellt und sich dort reinarbeitet, welche Links benötigt werden, kann ich Interessierten gerne erklären.
Man kommt zwangsläufig auf Shares wie TNTU, die vor einem Monat bei 0,90 auf ATH waren und vor einer Woche wieder bei 1,05 plötzlich auf ATH waren. Dann schaut man genauer hin, liest von China und Education Software und kann kaum was falsch machen.
Uns schwubs kosten sie 1,80.
Solche Chancen entdeckt man nur durch screenen, bei über 50.000 gelisteten Shares in den USA, braucht man Programme, die einem diese Arbeit abnehmen und Menschen, die  bereit sind, systematisch zu arbeiten.
Also Angebote zur Mitarbeit sind reichlich vorhanden, wer noch nicht wusste was er machen kann, ist herzlich eingeladen.

Gruss E.

Zum US-Depot für ESKIVANA. 1323433

TNTU  1.80  +0.23 
Mon Dec 29, 2003
Tengtu Launches Three New Software Products Business Wire - 03:27 PM EST
Tue Dec 23, 2003
Tengtu Software Recognized By China Education Technology Association Business Wire - 02:02 PM EST
Thu Dec 18, 2003
Tengtu Annual Meeting Scheduled for January 20, 2004 Business Wire - 06:03 PM EST
Wed Dec 17, 2003
Tengtu and China Hewlett-Packard Sign Cooperation Agreement Business Wire - 12:22 PM EST
Fri Dec 05, 2003
Tengtu Connects 578 Schools In Jiangxi Province Business Wire - 12:25 PM EST
Fri Nov 14, 2003
Tengtu Announces First Quarter Results Business Wire - 05:45 PM EST
Wed Oct 29, 2003
Tengtu Expands School Network in Shaanxi Province Business Wire - 11:37 AM EST
Fri Oct 24, 2003
Tengtu Mourns The Passing Of Zhang, Fan Qi Business Wire - 12:52 PM EDT
Tue Oct 14, 2003
Tengtu Announces Annual and Fourth Quarter Results Business Wire - 07:22 PM EDT

Friday, January 02, 2004 03:59 PM EST.  Quote delayed: 15 minutes Nasdaq, 20 minutes others.

Antworten
big lebowsky:

Eski,war ein gutes Telefonat,

 
03.01.04 23:27
wie Deine Taten beweisen.Ich werde gerne einiges umsetzen.CBS bekomme ich unter Big charts als link.Free Real Time kwenne ich,aber Zack muss ich suchen...

Ciao B.L.
Antworten
Reila:

Hehe, Eskimato,

 
04.01.04 08:07
toll, dass Du wieder oben bist. Will gern nach Deiner Anleitung mitarbeiten. Brauche aber etwas Zeit, da ich im vergangenen Jahr ein völlig neues Geschäftsfeld eröffnet habe und mich nicht zerteilen kann. Überarbeite gerade die Marketingkonzeption. Und da geht es um to be or not to be.
Denke, mit Eskivana kommt eine richtig tolle Sache ins Laufen.
Antworten
Eskimato:

Viel Erfolg Reila mit deinem neuen Geschäftsfeld.

 
04.01.04 16:44
Schön, dass Du bereit bist etwas zu übernehmen. big l. will auch von dem täglichen Research etwas machen.
6 Leute für den Research wären schon optimal, je zwei für die angedeutete Informationsbeschaffung. Also bei 30 Mitgliedern wird sich vielleicht noch jemand finden.

Gruss E.
Antworten
MarS:

würde auch einen Teil Research übernehmen

 
04.01.04 17:24
bräuchte aber schon nähere Angaben zum systematischen Screenen nach deinen Vorgaben.
Möchtest du das im nächsten Treffen am 17.1 erklären ?
Gruss,
MarS
Antworten
Eskimato:

Wenn wir dafür Zeit finden gerne.

 
04.01.04 17:42
Das bezweifele ich allerdings. Aber Deine Hilfe nehme ich gerne an. Wir könnten einen E-Mail-Kontakt auch mit anderen Interessierten aufbauen und uns die Ergebnisse der Screens mitteilen.
Welche Links benötigt werden und wie man es aufbaut ist gar nicht so schwer.  DSL und EXCEL-Kenntnisse wären als Voraussetzungen hilfreich.
Schreib mir ne kurze Mail, ich melde mich.
Jetzt bin ich weg für heute, hab keine Zeit mehr heute.

Gruss E.
Antworten
8x4udTgm:

würde mich auch gerne an der

 
04.01.04 17:44
Nachäffung von so genannten Investmentclubs beteiligen, wenn da nicht dieses abschreckende Hick-Hack-Beispiel bei Ariva wäre.
Antworten
Eskimato:

Aller Anfang ist schwer.

 
04.01.04 17:53
8 x 4, wir haben Aufnahmestopp bis Ende 2004. Wir müssen erst mit uns klar kommen und gute Strukturen erfinden.
Mal abwarten, wie attraktiv es überhaupt wird für Beobachter, bei uns kommendes Jahr einzusteigen.
Abgeschreckt bist Du jetzt schon, also verpasst Du erstmal nichts.
Muss jetzt los.

Tschüss E.
Antworten
patznjeschniki:

Helfe beim Screenen

 
05.01.04 00:36
Wenn niemand was dagegen hat. Hatte eben schon nen schönen Text geschrieben, dann hat mein Touchpad mal wieder rumgesponnen und die Arivapage geschlossen :( Brauche noch Seiten, wo man Tagesgewinner und Wochengewinner findet, nicht Branchenintern. Dito für Jahreshochs. Langfristiges Screenen geht schon. Hab eben beim aktuellen Screening NamensKonkurrenz gefunden. Sonic Solutions (SNIC), schöne Zahlen, schnuggeliger Chart

Zum US-Depot für ESKIVANA. 1323986chart.bigcharts.com/bc3/quickchart/...10&mocktick=1&rand=8572" style="max-width:560px" >


patzi
Antworten
Eskimato:

Morgen Patzi.

 
05.01.04 06:56
Auf Barchart.com z.B. findest Du alles was Du brauchst. Nicht meine Lieblingsseite, aber die für Kursverläufe an der OTC, daily, weekly, monthly kenne ich keine Bessere.
Natürlich auch alle gewünschten Kriterien an den anderen Börsenplätzen.
Übrigens hatte big l. SNIC letztes Jahr zu 5,65 im Wettbewerb mal reingenommen, ist kein
unbekannter Share. Dann aber ausgestoppt worden zu etwa dem gleichen Kurs. Danach hat er immer hinterher geschaut. Die Stoppkurse sind nicht so eine einfache Angelegenheit....

Gruss E.
Antworten
Eskimato:

Zu Posting Nr.4.

 
06.01.04 07:21

Jungs, Movers and Shakers lohnt...
Mach doch mal bitte einer ne tägliche Kolumne auf, schon wegen HIHO, standen dort drin...

Gruss E.

HIGHWAY HOLDINGS LIMITED - Nasdaq National Market: HIHO
Real-time ECN Quote*

LastChange (%)After Hours Chg (%)**Trade TimeBidAsk
7.45Zum US-Depot für ESKIVANA. 1325520quotes.freerealtime.com/gra/uparrow1.gif" style="max-width:560px" > 2.05 (37.96)Zum US-Depot für ESKIVANA. 1325520quotes.freerealtime.com/gra/uparrow1.gif" style="max-width:560px" > 0.06 (0.81)18:540 (0)0 (0)


Exchange Quote

LastChange (%)Trade TimeBid (size)Ask (size)
7.39Zum US-Depot für ESKIVANA. 1325520quotes.freerealtime.com/gra/uparrow1.gif" style="max-width:560px" > 1.99 (36.85)2004-01-050.04 (1)892 (1)
Latest TicksPrev CloseOpenLowHigh
+===5.406.115.367.81
Day VolumeAvg Day VolVWAP52 Wk Low52 Wk High
653,13938,4006.54540.665.80
# of TradesLast SizeAvg Trade SizeP/E RatioMarket Cap (mil)
1,5571004193422
1:19:42 AM EST - Tuesday, January 6, 2004- Exchange quote is delayed at least 15 minutes.

Antworten
big lebowsky:

HiHaHo-Eski,

 
06.01.04 08:11
wird erledigt.Ich bin leider technisch unbedarft,im Übrigen hatte ich Shover und Maker immer über Big Charts reingezogen.Dort gibt es so einen Link...

Ich werde mal sehen,ob ich das ab 17.01 übernehmen kann.Gern im Wechsel mit einem Mitgesellschafter.Das wäre mal etwas!!!!

Ciao B.L.
Antworten
patznjeschniki:

Heutige Aktien mit GapUps

 
06.01.04 17:58
Zum US-Depot für ESKIVANA. 1326404


patzi
Antworten
Eskimato:

Weiter so Patzi.

 
06.01.04 18:08
Prima Arbeit.

ARRS hatte ich in der letzten Runde 2003 drin, zu CHRB hab ich gestern und vorgestern geschrieben. CHRB gabs am 27.12. noch für 5,60.
Bei STTX wäre ich vorsichtig, die standen plötzlich als Sell-Highlight bei Zacks.
Wird Zeit, dass wir an den Markt kommen.
Werde jetzt mal die Screening-Anfragen von Mars und buju beantworten und Dir ne Kopie schicken.
Hattest Du Dir Barchart.com auch mal angesehen?

Gruss E.
Antworten
patznjeschniki:

AUGT mustergültig ausgebrochen - neues ATH

 
06.01.04 18:13
$22.74
Zum US-Depot für ESKIVANA. 1326419chart.bigcharts.com/bc3/quickchart/...75&mocktick=1&rand=9294" style="max-width:560px" >

Zum US-Depot für ESKIVANA. 1326419chart.bigcharts.com/bc3/quickchart/...60&mocktick=1&rand=1362" style="max-width:560px" >


August Technology Raises 4th-Quarter Revenue Outlook


Tuesday January 6, 10:16 am ET


MINNEAPOLIS (Dow Jones)--August Technology Corp. (NasdaqNM:AUGT - News) raised its revenue estimate for the fourth quarter ended Dec. 31 following a general industry upturn, a company spokesperson said, which helped increase sales across all product lines.
In a press release Tuesday, the company, which makes quality control systems for electronics manufacturers, said it now expects quarterly revenue of about $ 14 million, up 20% from third-quarter levels and more than double the $6.3 million it recorded in the fourth-quarter of 2002.

Previously, August Technology forecast a 5% to 15% sequential increase in fourth-quarter revenue.

Analysts polled by Thomson First Call (News - Websites) , on average, expect the company's fourth-quarter sales to total $12.8 million.

August Technology projected 2003 revenue of about $40 million, compared with $ 25.1 million a year ago and analyst estimates of $38.8 million.

The company also said orders again grew faster than revenue in the fourth quarter, marking its sixth consecutive period of a book-to-bill ratio above parity.

August Technology shares recently traded at $21.50, up $1.03, or 5%, on heavy volume.

Company Web site: www.augusttech.com



patzi
Antworten
patznjeschniki:

ARRY - Allianz mit Gententech

 
06.01.04 18:31
Der TopWert auf obiger Liste. Deren Zeuch scheint gefragt!

$7.92
Zum US-Depot für ESKIVANA. 1326440chart.bigcharts.com/bc3/quickchart/...64&mocktick=1&rand=5097" style="max-width:560px" >

Zum US-Depot für ESKIVANA. 1326440chart.bigcharts.com/bc3/quickchart/...49&mocktick=1&rand=4965" style="max-width:560px" >


Array shares jump on alliance with Genentech


Tuesday January 6, 10:24 am ET

NEW YORK, Jan 6 (Reuters) - Shares of Array BioPharma (NasdaqNM:ARRY - News) rose as much as 33 percent on Tuesday after the company said it formed a licensing agreement with Genentech Inc. (NYSE:DNA - News) to develop cancer drugs.

Array said it will receive an upfront payment of an undisclosed sum, funding for its research, additional payments for certain development milestones and royalties on any products that reach the market.

The agreement comes less than three weeks after the company signed a similar agreement with AstraZeneca Plc (London:AZN.L - News) under which AstraZeneca receives rights to an Array drug known as ARRY-142886 and to certain second-generation compounds for cancer.

Under its agreement with Genentech, which sells the breast cancer drug Herceptin (News - Websites) , the companies will collaborate on discovering potential compounds directed against two cancer targets. Genentech will have the sole responsibility for the clinical development and commercialization of any products developed.

Genentech also has the right to add additional programs to the collaboration.

Array's shares were up $1.93, or 32 percent, to $7.96 in midmorning trading on Nasdaq. Earlier they rose as high as $8.00.


patzi
Antworten
baanbruch:

Nix all-time-high und nix gap !

 
06.01.04 22:24
Möchte nur noch mal an mein Biotop deCode (DCGN)
erinnern.
Könnt Ihr Euch ja mal unter charttechnischen Aspekten ansehen.
Technisches Kaufsignal ist wohl keins da.
Aber ich finde, die news werden immer besser.
Als ich die erstmals kaufte, meinten meine Kontakte in Skandinavien
zum abbröckelnden Kurs an der Nasdaq: Die Amis wollen ein "product".
deCode hat keins.

Nun, inzwischen haben sie mehr als eins.
Ich habe ein Gefühl, als wenn deCode eines Tages mal einen Rambus
machen (steiler Anstieg in wenigen Wochen). Wann ? Keine Ahnung.
Aber wenn die Bomben-news da ist, kommt der Einstieg zu spät.
Selber konnte ich deCode immer nur in BRD ordern und oft ging tagelang
nix um. Aber wo wir jetzt direkt anne Quelle mitmischen können, fände ich
eine kleinere Position (längerfristig) nicht schlecht. Kauf mit Abstauberlimit.


Meinungen ?

Gruß
baanbruch
Antworten
big lebowsky:

Meine SEAC laufen auch gut-Empfehlungsliste

 
06.01.04 23:06

Zum US-Depot für ESKIVANA. 1326724chart.bigcharts.com/bc3/quickchart/...ocktick=1&rand=1832" style="max-width:560px" border=0>

 

 

ELNK spiele ich im Depotwettbewerb!

Antworten
Gruenspan:

@ Herr Geschäftsführer

 
07.01.04 00:28
Gibt es neue Nachrichten von den E- Tretern?

Endlich alle Postler durch?

Es zieht sich hin und hin und hin und ........

Jede Menge Werte Infos und weitere Links zu HOCH`s UND TIEF`s samt Geschichte dazu gibt es bei u.a.

www.tradingday.com
www.sectorupdates.com

Prognosen angehoben hat der Breitband Provider ARRIS Ticker (ARRS)


       Zum US-Depot für ESKIVANA. 1326766
     








Antworten
patznjeschniki:

IPOs 2oo3

 
07.01.04 02:49
Originalartikel


Pivotal Year for IPOs Ends on High Note


Sunday December 28, 12:33 pm ET
By Steve James


NEW YORK (Reuters) - In a year that many believe marks a turnaround in the market for initial public offerings, there were some spectacular winners, some big-name deals and a few poor performers.
According to Dealogic, an IPO financial data provider, 85 IPOs were completed in 2003, the same as the year before. The total this year was driven by a busy December, which experts say bodes well for 2004.


Bankers priced only 10 IPOs after the first six months of the year, but there was a flood of new issues in the second half, when uncertainty over the war in Iraq and the U.S. economy dissipated. There were 21 deals done in the third quarter and 54 in fourth.

Bankers priced 24 IPOs in December alone, making it the most productive month in three years since 27 deals in October 2000, according to John Fitzgibbon, editor of 123jump.com, an online IPO monitor.

"The wind was clearly at the IPO market's back this year," Fitzgibbon said.

"It certainly is heating up," said Lawrence Calahan, a partner at America's Growth Capital in Boston, an investment bank specializing in emerging growth. "The year seemed to gain steam, especially after the end of the war (in Iraq).

JUMPING BACK IN

"People were cautious but with the market showing signs of life they decided to jump back in," he told Reuters. "The public market has bounced back quicker than we anticipated, but there are still people who think maybe the market has got ahead of itself. But generally the attitude is positive.

"The expectation is that the first quarter will be equally, or more robust (than the fourth quarter)," Calahan said.

According to America's Growth Capital figures, the technology, financial, consumer and real estate sectors were more attractive to investors looking for new public companies.

Health-care and transportation IPOs generally did not fare as well.

The biggest overall winner of 2003 in aftermarket performance was Accredited Home Lenders Holding Co. (NasdaqNM:LEND - News), a San Diego-based non-prime mortgage banker. It was priced in February at $8 and has climbed over 300 percent higher to more than $32. On Friday, the stock closed at $30.39 on Nasdaq.

Another mortgage firm, Franklin Bank Corp. (NasdaqNM:FBTX - News) was also well ahead of the game after pricing at $14.50 each. The IPO opened at $16.74 a share on Dec. 18, and closed Dec. 19 at $17.50 a share, up 20.7 percent. On Friday, the Houston-based savings and loan closed at $18.75 on Nasdaq.

Also in the financial sector, Infinity Property & Casualty Corp. (NasdaqNM:IPCC - News) has more than doubled its $16 IPO price and closed at $30.50 Friday on Nasdaq.

One rust-belt industry IPO -- International Steel Group Inc. (NYSE:ISG - News) -- was a surprise success, climbing 48 percent in its first two weeks. Shares closed at $40.78 Friday on the New York Stock Exchange (News - Websites) .

On the downside, shares of Acusphere Inc. (NasdaqNM:ACUS - News), a developer of drugs to treat the central nervous system, dropped more than 50 percent after its October IPO price of $14 to a low of $6.70. It traded down 19 cents at $8.09 Friday on Nasdaq.

Another health-care flop was NitroMed Inc. (NasdaqNM:NTMD - News), a pharmaceutical company developing drugs for heart failure in black patients. It priced its IPO at $11 on Nov. 5 and fell 15 percent on the first day of Nasdaq trading. On Friday, it rose 5 cents to $7.10.

Big-name deals grabbed the headlines in December -- China Life Insurance Co. Ltd. (NYSE:LFC - News; HKSE:2628.HK - News) and Orbitz Inc. (NasdaqNM:ORBZ - News), with differing results.

China Life, China's largest life insurer, had an estimated IPO value of $3.46 billion, making it the biggest of the year. The offering was priced at $18.68 and started trading on the New York Stock Exchange on Dec. 17 at $23.25, rising 27 percent on the first day. On Friday, it closed up $1.51 to $32.01.

Another Chinese IPO, online travel and hotel booking firm Ctrip.com International (NasdaqNM:CTRP - News), was 80 per cent up from the IPO price. It closed Friday at $33.90 on Nasdaq, up 91 cents.

In contrast, the anticipated offering of the U.S. online travel company Orbitz was less than stellar. The shares fell about 4 percent on the first day of trading on Nasdaq, after initially rising 18 percent over the IPO price of $26.

The next day it hit a low of $22.77, but despite rising since, it was still below the IPO price and closed Friday at $23.63 on Nasdaq, down 33 cents.



Bitte LEND besonders beachten!!

$3o.3o   KGV 'o4: 6
Zum US-Depot für ESKIVANA. 1326783


patzi
Antworten
Ca.Gouverneur:

@Eskimato was ist mit EDGR? Der schnell kaufen Tip o. T.

 
07.01.04 09:36
Antworten
patznjeschniki:

GapUpAktien

 
07.01.04 16:35
Zum US-Depot für ESKIVANA. 1327584


patzi
Antworten
Parocorp:

patzi bei dir ist

 
07.01.04 16:37
DUK in der liste...

gestern abend gekauft (20,08$) vorboerse verkauft (21,20$)

jetzt wieder 21$...

so macht das spass ;-)

gruss
Antworten
baanbruch:

Nix weltbewegendes.

 
07.01.04 16:38
Aber ein weiterer Beweis: deCode is alive and kicking !



deCODE and The Simons Foundation Launch Major Population-based Study of the Genetics of Autism
Wednesday January 7, 5:00 am ET


REYKJAVIK, Iceland, Jan. 7 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN - News) and The Simons Foundation, a New York-based organization supporting advanced research in the basic sciences, today announced the launch of the first ever population-based study of the genetics of autism and autism spectrum disorders (ASDs). Funded by a two-year, $2.8 million grant from The Simons Foundation, deCODE has begun a population- and genome-wide gene discovery effort aimed at identifying the key genetic components of these disorders. It is well established that these conditions run in families, but the identification of the specific inherited causes may provide valuable insight into the neurological dysfunctions they evoke. Knowledge of the biology of these disorders may in turn clarify the role of environmental factors and contribute to the development of new methods of diagnosis and treatment.
ADVERTISEMENT


The deCODE study will bring together detailed genotypic and clinical data on individuals diagnosed with autism and ASDs, as well as genotypic data and information from detailed questionnaires on aspects of social communication and other behavioral characteristics from first and second degree relatives. In total, the study aims to include several hundred individuals with autism and ASDs, and several thousand of their relatives. The ability to assemble such comprehensive clinical and behavioral data for population-wide linkage analysis offers an unprecedented opportunity not only for identifying key genes linked to these disorders but also for pinpointing which elements of these complex phenotypes are inherited.

In this program the deCODE team is working with the National Diagnostic and Counseling Center, which carries out diagnostic evaluations and oversees therapy for children and adolescents with autism and related spectrum disorders throughout Iceland, as well as the Icelandic Autism Support Network, an organization of families and caregivers, and physicians and psychologists at the Department of Child and Adolescent Psychiatry at the National University Hospital. Dr. Catherine Lord of the University of Michigan, a renowned expert in this field, is serving as a clinical advisor, assisting the deCODE team in the development and analysis of the questionnaires that will be given to family members. The questionnaires are designed to capture often subtle behavioral and personality traits which, although not clinically relevant on their own, may in certain combinations or in extreme forms constitute important components of these disorders.

"We are very excited to begin tackling the genetics of autism and autistic spectrum disorders. Our discoveries in other neurological and behavioral disorders like schizophrenia, anxiety and depression demonstrate that our population approach has the power to pull out major genes even in the most complex disorders the basic biology of which is little understood. I am confident that we will succeed in autism as well, and we and our collaborators are very grateful to the Simons Foundation for their support for this project," said Kari Stefansson, CEO of deCODE.

"We are very pleased to be working with deCODE on this project. It represents a crucial component in our foundation's new program to search out the root causes of autism, a condition which affects very many people around the world. We believe that deCODE's proven expertise has a great chance to prove highly successful and we are delighted to be associated with so fine an organization," said Jim Simons, founder of the Simons Foundation.


Antworten
patznjeschniki:

IVOC

 
07.01.04 16:44
Aktueller MomentumPlayer. Gestern 8o% heute wieder knapp 4o%. Haben ein Patent auf Spracherkennungssoftware erhalten. Nachricht anbei. Bei einer Bewertung von knapp $22 mio. scheint noch Platz nach oben.

$o.oo89
Zum US-Depot für ESKIVANA. 1327603chart.bigcharts.com/bc3/intchart/frames/...and=670&mocktick=1" style="max-width:560px" >



Second Patent Award Received by iVoice from U.S. Patent and Trademark Office


Tuesday January 6, 7:01 am ET


MATAWAN, N.J.--(BUSINESS WIRE)--Jan. 6, 2004--iVoice, Inc. (OTC Bulletin Board: IVOC - News), a leader in speech recognition technology, today announced today it has received United States Patent 6,671,354 for a patent for a Speech-Enabled Automatic Telephone Dialer without the need for a PBX. This technology uses a seamless interface with computer based address book programs such as Microsoft® Outlook®. "iVoice will be offering the opportunity for companies to procure the rights to the technology under licensing agreements under which iVoice would receive compensation on a royalty basis" said Jerry Mahoney, of iVoice, Inc.
"The grant of this patent is centrally important to iVoice, Inc. not only to defend its technology but also to leverage offensively in the marketplace" added Mr. Mahoney. "We believe that any name dialer solution sufficient to satisfy the minimum customer requirements will require either a license from us under one or more of our patents or many years of research and development in search of an alternative solution" he furthered.

With the worldwide explosion in the usage of mobile phones, clients are seeking easier and more convenient ways of accessing information and conducting business. Speech-enabled solutions such as the iVoice Name Dialer help meet this demand -- enabling users to stay connected to the people and information they need, when and where they need it. Speech Enabled enhanced services can also benefit telecommunications carriers by helping them provide value-added services to their customer base.

The present invention is a speech enabled automatic telephone dialer device, system, and method using a spoken name corresponding to name/telephone number data of computer-based address book programs. The Speech Enabled Name Dialer imports all of the names and telephone numbers from your existing Microsoft Outlook, ACT, Gold Mine or other contact management software and can automatically connect you with anyone you ask for. You simply pick up the phone, tell the Name Dialer the name of the person you want to contact, and the Name Dialer finds the telephone number and dials for you. All of your contacts are made available by name or number, at anytime, from anyplace.

About iVoice, Inc.

iVoice, Inc. designs, manufactures and markets innovative voice activated computerized telephone applications for businesses and corporate departments. Our Speech Enabled Auto Attendant allows callers to contact their intended party using their spoken voice, eliminating cumbersome dial by name or extension menus. Our Interactive Voice Response (IVR) products allow information in PC databases to be accessed via voice or from a standard touch-tone telephone. iVoice products are designed to be simple for the end user and provide a cohesive system to access messaging systems.

NOTE: Any statements that are not historical facts contained in this release are forward-looking statements. It is possible that the assumptions made by management for purposes of such statements may not materialize. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements may involve risks and uncertainties, including but not limited to those relating to product demand, pricing, market acceptance, the effect of economic conditions, and intellectual property rights, and the outcome of competitive products, risks in product development, the results of financing effort, the ability to complete transactions, and other risks identified in this release, and the Company's Securities and Exchange Commission filings.


patzi
Antworten
Eskimato:

Doc Broemme hatte XMSR

 
07.01.04 20:24
Anfang letztes Jahres zu 7 gekauft, na ja. BKST hat heute die Prognosen fürs Gesamtjahr angehoben.
Ich hab 10 Millionen Volumen bei ARRS heute. Ob uns Grueni wohl heute mit AIRN gezockt hatte?

Gruss E.
Antworten
Gruenspan:

Tagesbeitrag!

 
07.01.04 22:26
Einen kriege ich vielleicht täglich hier hin.
Für die große Story fehlt mir aber die Zeit.

       Zum US-Depot für ESKIVANA. 1328157

Diodes gets lift from Q4 outlook.

US- Ticker DIOD   close $22,10  

Eski, nö hat er nich.




                         Gr.Gr.    
Antworten
Eskimato:

Kaufempfehlung Collins und Aikman CKC

 
08.01.04 06:04

Danach reichts mir aber, können wir eh  nicht alle kaufen. Also erstmal keine Geschichten mehr von mir.

Wenn wir dann wirklich ran können, wird neu besprochen.

Gruss E.

CKC  6.44  +1.38 
Mon Jan 05, 2004
India Satyam To Set Up Design Center For U.S. Co Dow Jones - 02:54 AM EST
Fri Dec 19, 2003
Alert: Oppenheimer upgrades CKC to Buy Briefing.com - 12:00 PM EST
Tue Nov 25, 2003
Collins & Aikman Awarded Future Business with Volvo Car Corporation PR Newswire - 09:07 AM EST
Fri Nov 21, 2003
Collins & Aikman Receives KIA Motors America, Inc.'s 'Most Valued Partner' Award PR Newswire - 09:29 AM EST
Wed Nov 19, 2003
Collins & Aikman Receives Honda Access America, Inc.'s 'Best Supporting Supplier' Award PR Newswire - 01:06 PM EST
Thu Nov 13, 2003
Collins & Aikman Announces Improved Third Quarter Financial Results PR Newswire - 11:59 AM EST
Wed Nov 12, 2003
Collins & Aikman to Webcast and Teleconference Third Quarter Financial Results on November 13, 2003 PR Newswire - 01:16 PM EST
Thu Nov 06, 2003
Collins & Aikman Confirms Strategy for New Business PR Newswire - 10:05 AM EST
Wed Oct 15, 2003
Collins & Aikman and UAW Announce Neutrality Agreement PR Newswire - 02:30 PM EDT
Fri Oct 10, 2003
Collins & Aikman Awarded Ford Futura Interior Systems Business PR Newswire - 08:01 AM EDT

Antworten
patznjeschniki:

Tagesgewinner im S&P500

 
08.01.04 21:49
Zum US-Depot für ESKIVANA. 1329714


patzi
Antworten
patznjeschniki:

US-Aktien mit neuen Jahreshochs

 
08.01.04 21:52
Zum US-Depot für ESKIVANA. 1329718


patzi
Antworten
patznjeschniki:

Blocktrades

 
08.01.04 21:56
Zum US-Depot für ESKIVANA. 1329726


patzi
Antworten
Dr.UdoBroem.:

Neues Jahreshoch?

 
08.01.04 22:11
Zum US-Depot für ESKIVANA. 1329739chart.bigcharts.com/bc3/quickchart/...04&mocktick=1&rand=9493" style="max-width:560px" >



Antworten
Gruenspan:

Am Ende werden

 
08.01.04 22:20
es die Eskivana- Trader schwer haben die richtigen Werte zu finden.
Es könnte sein, datt, wenn "vielleicht" im Februar selbige Trader in Aktion treten können, eher die Momentum- Player im Vorteil sind.

Antworten
Gruenspan:

Hmmmm

 
08.01.04 23:19
       Zum US-Depot für ESKIVANA. 1329784

Es müssen doch nich nur Werte auf 52 WH sein, oder?      
Antworten
big lebowsky:

Jungs,dat sieht wirklich gut aus! o. T.

 
08.01.04 23:28
Antworten
Nassie:

Das Engagement ist

 
08.01.04 23:38
bemerkenswert. Aber der Trend ist auch fuer uns.
Antworten
Eskimato:

Trotzdem wirds schwer.

 
09.01.04 05:24
Wenn sich das weiter wie Kaugummi hinzieht bis wir in die Pötte kommen, ist die Hausse gelaufen. Der Markt wird konsolidieren, ein bisschen Wasser in den Wein.

Gruss E.
Antworten
patznjeschniki:

GapUpAktien

 
09.01.04 17:10
Zum US-Depot für ESKIVANA. 1331019


patzi
Antworten
patznjeschniki:

...in Frage kommen Aktien wie ... CYAN

 
09.01.04 17:17
$2.2o
Zum US-Depot für ESKIVANA. 1331038chart.bigcharts.com/bc3/intchart/frames/...nd=1335&mocktick=1" style="max-width:560px" >

Zitat Eskimato, Posting 1.


patzi
Antworten
Eskimato:

SNRN als spekulative Beilage gefällt mir gut.

 
09.01.04 17:19
Steht hier bei den Minenaktien, das fünfte Thema....... Dieser kleine Explorer mischt im Irak mit, stand in allen AdHocs der letzten Wochen, heute diese AdHoc:

Sonoran Energy to Open Office in Iraq  


LONDON, Jan 9, 2004 (BUSINESS WIRE) -- Sonoran Energy, Inc. (OTCBB: SNRN)
President and CEO Paul Bristol, who is visiting Baghdad, announced today that
the Company intends to open an office in Iraq within the next 30 days. The
office, which will be located in Baghdad, will be used to support the Company's
planned oil and gas development program in Iraq. The operation in Baghdad will
be manned by Iraqi oil experts.

"To operate successfully in Iraq it is imperative that we have a strong
in-country presence," said Paul Bristol, President and CEO, who was recently
working with the Iraqi Oil Ministry in organizing a conference in Baghdad. "Over
the next few weeks we will be identifying several oil and gas opportunities in
Iraq and our team will need to establish itself in the local business community.
We have considerable confidence in Iraqis and we will be announcing our Iraqi
partner in the very near future."

About Sonoran Energy

Sonoran Energy's primary objective is to build itself into a major oil and gas
corporation concentrating mainly in Iraq, but with a background of developing
oil properties in North America.

This news release contains forward-looking statements that are subject to
certain risks and uncertainties that may cause actual results to differ
materially from those projected on the basis of such forward-looking statements.
Such forward-looking statements are made based upon management's beliefs, as
well as assumptions made by, and information currently available to, management
pursuant to the "safe-harbor" provisions of the Private Securities Litigation
Reform Act of 1995.

SOURCE: Sonoran Energy, Inc.


Antworten
Eskimato:

SNRN-News

 
12.01.04 17:51
Gruss E.

chart.bigcharts.com/bc3/quickchart/...45&mocktick=1&rand=8773"

Sonoran Energy Names Former Amerada Hess Executive as Chief Operating Officer; Peter Ostenfeld-Rosenthal Joins Management Team  


LONDON, ENGLAND, Jan 12, 2004 (CCNMatthews via COMTEX) -- Sonoran Energy, Inc.
(OTCBB: SNRN) announced today that it has appointed Peter Ostenfeld-Rosenthal to
be chief operating officer of the Company.

Paul Bristol, the chairman and CEO of Sonoran Energy, said, "For Sonoran Energy
to realize its potential within the near term, it was imperative to add depth to
our management team. We are delighted to have Peter on board and to have greatly
enhanced our ability to pursue oil and gas opportunities in the Middle East. We
are completely focused on moving forward with a property acquisition program in
Iraq, and now with a seasoned petroleum industry manager such as Peter on our
team we are better able to manage our expansion into the Region."

Mr. Ostenfeld-Rosenthal, 41, a civil engineer, was most recently General Manager
- Aberdeen Operations for Amerada Hess Corporation (NYSE:AHC), a global
integrated energy company engaged in the exploration for and the production,
purchase, transportation and sale of crude oil and natural gas, as well as the
production and sale of refined petroleum products. Mr. Ostenfeld-Rosenthal was
previously employed by Elf Petroleum Norge from 1993 to 1997, serving as
Specialist Engineer, Project Manager and Implementation Superintendent. Prior to
joining Elf Petroleum Norge he worked as a consulting engineer assisting with
the development of new concepts for floating Oil & Gas facilities, developing
technical and commercial proposals for clients such as Chevron, Mobil and Shell,
and project management of various projects, mainly within structural reliability
and risk analysis (both technical and financial).

About Sonoran Energy

Sonoran Energy's primary objective is to build itself into a major oil and gas
corporation concentrating mainly in Iraq, but with a background of developing
oil properties in North America.

This news release contains forward-looking statements that are subject to
certain risks and uncertainties that may cause actual results to differ
materially from those projected on the basis of such forward-looking statements.
Such forward-looking statements are made based upon management's beliefs, as
well as assumptions made by, and information currently available to, management
pursuant to the "safe-harbor" provisions of the Private Securities Litigation
Reform Act of 1995.



CONTACT:          Sonoran Energy, Inc.

                 Paul Bristol

                 President & CEO

                 +44 (0) 20 7582 6222 or North America: 866-599-7676

                 Website: www.sonoranenergy.com



Antworten
patznjeschniki:

Jahreshochs

 
12.01.04 21:35
Zum US-Depot für ESKIVANA. 1334275

patzi
Antworten
patznjeschniki:

INSG

 
13.01.04 17:04
Zum US-Depot für ESKIVANA. 1335528chart.bigcharts.com/bc3/intchart/frames/...nd=3148&mocktick=1" style="max-width:560px" >

Gehen heute nach der Meldung von einer Kooperation mit IBM mächtig ab.


Insignia Solutions in Development Pact With IBM
Tuesday January 13, 9:10 am ET


FREMONT, Calif. (Dow Jones)--Insignia Solutions PLC (NasdaqSC:INSG - News) signed a definitive agreement with International Business Machines Corp. (NYSE:IBM - News) to create a system for managing and updating mobile phones.
ADVERTISEMENT


In a press release Tuesday, Insignia said it will integrate its server software product onto IBM's Websphere platform. Insignia's server software product gives an update system for mobile operators and phone operators, while IBM's system provides mobile device management middleware.

The companies plan to co-market the new system to mobile operators and phone manufacturers. Financial terms of the deal weren't disclosed.

Insignia's shares more than doubled in premarket trading to $2.62, according to INET. The shares closed the regular Nasdaq market session Monday at 99 cents.


patzi
Antworten
Eskimato:

patzi, es geht mir um Folgendes:

 
13.01.04 18:59
Alleine die Veröffentlichung der neuen ATHs ist richtig, nur das dort ATTU, RAE, CMTL, NWK, OMCL und die anderen Flyer fast jeden Tag auftauchen.
Meine Mail zielte darauf ab, eine Arbeitsweise zu entwickeln, die wirklich neue Shares rausfiltert. Die oben genannten sind ohnehin in der WL.
Vielleicht verständigen wir uns in Berlin oder per Mail auf eine gemeinsame WL, die wir uns beinahe täglich anschauen. Du musst mir nur sagen, wieviel Werte Du maximal möchtest.
Mit Excel hab ich eine eine WL von über 2000 Werten.

Eine gemeinsame WL von vielleicht 100 Werten für den Anfang wäre ein Beginn. Mit buju mach ich das über den Umweg Börsenspiel beinahe so. Er hatte sich Funkwerk für 22 ins Depot geladen, das hab ich dann auch gemacht, weil es guter Trade-Einstiegszeitpunkt war.

Schade, dass wir SNRN noch nicht für Eskivana kaufen konnten, ein Top-Tipp ala Eskimato, da bin ich sehr mit zufrieden...

Gruss E.
Antworten
patznjeschniki:

Eski

 
13.01.04 22:24
Ich entdecke tätglich neue geile Werte. Aber wie stellst du dir das vor? Soll ich dann jeweils den Ticker hier rein stellen, oder den Chart. Meist hast du den Wert vor nem Jahr eh vorgestellt.


patzi
Antworten
buju:

Jepp Eski, Patzi...das sollten wir am Samstag

 
13.01.04 22:30
klären, bin für US-Shares zu haben, auch wenn
ich damit ziemliches Neuland begehe, aber es
juckt unheimlich, nachdem ich am letzten Weekend
Darvas innerhalb von 24h verschluckt habe ;-)

hey ya, Buju Zum US-Depot für ESKIVANA. 1336222 
Antworten
patznjeschniki:

@buju

 
13.01.04 22:39
Hab das Buch noch nicht gelesen. Ich glaub, du hast es schon mal verlinkt? Kannst du das noch mal tun. Rede so oft davon, möchte ich den Quatsch doch auch mal lesen.


patzi
Antworten
Sitting Bull:

Stellt doch mal Euer

 
13.01.04 22:48
aktuelles Depot rein.
Antworten
big lebowsky:

@Sitting Bull

 
14.01.04 07:21
Du bist sicherlich der Allerletzte,der "unser" Depot sieht.Ich habe Dir im Zusammehang mit Eskivana alle Unterlagen per Post gesandt,über E-Mail mit Dir korrespondiert etc.

Dass Du Dich nicht für eine Teilnahme entschlossen hast,ist in Ordnung und kein Thema!Aber eine kurze Antwort: "Ich mache nicht mit" ggfs mit Dank für die Unterlagen hätte sich gehört.

Trittbrettfahrer brauchen wir nicht. Also,frag hier nicht nach Depots,sondern investiere selbst!

Ciao B.L.
Antworten
patznjeschniki:

ADZR - seit 46% on watch!

 
14.01.04 20:35
ADZR $o.65
Zum US-Depot für ESKIVANA. 1338023


Recent Price: (09-08-03): $0.10 Common Shares Out: 50.5 million
52-Week Range: $0.01-0.18 Market Cap. $5 million
Fiscal Year: March Investment Rating: BUY

Company Description: Launched in 2000, AdZone Research Inc. is an emerging growth company providing proprietary software that monitors the Internet for virtually all types of activity. The data is then segmented and sorted as needed. The company has developed three key focus areas: Online Advertising Data, Online Biotech Tracking and Online Terrorism Tracking. Its technology is scalable, and capable of supporting additional products and services of value to its numerous marketplaces. However, there is one area in particular that ADZR seems to be making a measurable impact: homeland security. The company’s proprietary software enables it to scan, identify and assess the Internet for information affecting national security. The company maintains its headquarters in Calverton, New York, in a secured facility that formerly housed major defense contractor Northrop Grumman Corporation.

Since September 11, 2001, the company has received many inquiries concerning the application of its technology in the war against terrorism.
Beginning in January 2003 the company began running its NetGetä technology on a daily basis, and since then the company has independently been credited with discovering and helping to thwart at least two confirmed terrorist plots.
Currently, there is substantial interest in ADZR’s capabilities, and the company has formed key strategic relationships with Raytheon (NYSE-RTN), Boeing, (NYSE-BA) and the Sarnoff Corporation.
In May of this year the company announced it had been awarded its first revenue generating contract from a major defense contractor, which was followed by another award just last week focused on the major contractor’s range of products and services aimed at identifying clandestine terrorist communications using the Internet, on behalf of federal agencies.
In addition to its work in tracking down Internet terrorist threats, the company also tracks the World Wide Web for other purposes. These include Internet advertising from various sources.
The company is led by a motivated and experienced team of executives whom, in our opinion, have the capabilities of leading ADZR through a period of rapid growth and development.
Recent Financial Results

AdZone research is a company that is still in the development stage, and the company’s financial results reflect that status. It should be noted the company’s financial statements still carry a "going concern opinion." Since the company has not fully commenced operations, management is of the opinion that current financial results are not meaningful as an indication of future operations. During the first quarter of Fiscal 2004 (year ending March 31, 2004), the company obtained a $50,000 contract from a major United States defense contractor. During the quarter, the Company completed and billed approximately $39,125. For the three months ended June 30, 2003, the Company incurred a net loss of approximately $77,000, as compared to a net loss of approximately $172,000 for the three months ended June 30, 2002. Based on the weighted-average number of shares of common stock issued and outstanding at June 30, 2003 and 2002, respectively, ADZR incurred a net loss per share of approximately $(0.00) and $(0.02). The Company had approximately $51,500 in available cash at June 30, 2003 as compared with $8,100 at March 31, 2003 and approximately $2,900 at June 30, 2002. The Company attempts to maintain a cash balance sufficient to sustain corporate operations until such time as management can raise the funding necessary to advance its business plan. Readers are urged to review ADZR’s full financial statements as contained in SEC Forms 10-KSB and 10-QSB. These forms are easily accessible on the Internet.

Future Prospects: In our opinion, AdZone Research is truly functioning at the highest levels of participation in the homeland security efforts, beyond anything the company can reveal. Much of the activity that the company is involved is classified. Accordingly, it’s very difficult to project exactly what the company’s future prospects hold. However, given recent announcements about another contract from a major defense contractor we believe there is reason to believe that revenue could build quickly over the next few years, particularly if, as we expect, more defense contractors sign on. Moreover, the nature of the services provided by ADZR is high-margin, suggesting that profitability can build rapidly.

Risk Level: High

Conclusion: Since our initial report on AdZone in October of 2002, the company has made significant progress. Of particular note are the contracts that have been obtained from a major defense contractor. We anticipate that in coming months the company will make more progress in obtaining contracts and that the investment community will truly start paying attention to the ADZR stock. Indeed, we believe that ADZR has tremendous upside potential from these levels and we continue to rate the stock a BUY.


In Zusammenhang mit der Aktie ist mir grad ne interessante Seite aufgefallen. (Hier klicken)


patzi
Antworten
Eskimato:

patzi, ist die Mail da?

 
14.01.04 20:38
Übrigens, zwei Doofe, ein Gedanke. Zu ADZR wollt ich auch was schreiben, hatte ich bei 0,33 mit neuem ATH gescreent, musste mich aber erst um die Mail kümmern.

Gruss E.
Antworten
patznjeschniki:

Ha, ich war mal schneller, yippie

 
14.01.04 20:44
Mail ist nicht angekommen! Hab eben grad nachgeschaut. Patznjeschniki@gmx.de
Antworten
Eskimato:

patzi, Mail sollte jetzt da sein.

 
14.01.04 20:56
Wenn Du Sie auch hast, darf ich annnehmen, dass alle ESKIVANER sie bekommen haben und kann beruhigt aus dem Haus gehen.

Gruss E.
Antworten
patznjeschniki:

Hab sie nicht! o. T.

 
14.01.04 21:05
Antworten
baanbruch:

Tja, wir müssen mal langsam in die Gänge kommen.

 
16.01.04 00:32
DeCode heute 14% und das ohne uns.

So jetzt müssen wir rein, laut Eskimato´s
Logik und der vieler anderer.

Welcome to a 52week high!

DCGN 9.90 Schlußkurs 15.01.04

Gruß
baanbruch
Antworten
patznjeschniki:

FARO

 
16.01.04 00:47
Baanbruch, hast schon recht. Die Rally läuft - ohne uns - aber wie lange noch?


Schau mir grad mal ein paar Fonds an und - siehe da, es gibt sogar einen, der TASR im Depot hat, als zweitgrößte Position. Die größte ist FARO

Zum US-Depot für ESKIVANA. 1340343

Zum Fond


patzi
Antworten
patznjeschniki:

He Eski, - TIVO

 
16.01.04 01:11
He Eski, schau dir mal bitte TIVO an, hier könnte ein langfristiger Turnaround anstehen!

Schaut ruhig mal die Werte im Fond durch, es lohnt sich!

TIVO $9.52
Zum US-Depot für ESKIVANA. 1340345chart.bigcharts.com/bc3/quickchart/...41&mocktick=1&rand=9845" style="max-width:560px" >


patzi
Antworten
patznjeschniki:

Eski - UCOMA KGV von 2?? o. T.

 
16.01.04 01:55
Antworten
patznjeschniki:

ADAT - geiler Chart - Dt. Firma!!

 
16.01.04 02:34
$16.7o
Zum US-Depot für ESKIVANA. 1340357


Schaut euch einfach mal ein wenig auf der Webite um, krasse Firma, krasse Kunden!


patzi
Antworten
Sitting Bull:

Big L,

 
16.01.04 16:08
nanu, so aggressiv. Keine Sorge, habe kein großes Interesse an Eurem Depot.

Antworten
Gruenspan:

! FIBR !

 
16.01.04 21:43
Nach den JNPR Earnings und Aussichten sind Networker gefragt.


FIBR stehen noch in den 04 er Startlöchern könnte man meinen.


       Zum US-Depot für ESKIVANA. 1341998
     
Antworten
Dr.UdoBroem.:

Sorrento Networks Closes $10 Million Financing

 
27.01.04 16:12
Dem Kurs tuts gut...

Zum US-Depot für ESKIVANA. 1356416
Truth is stranger than fiction, because fiction has to make sense
Antworten
der Tolle:

wo/wie kann man denn euer depot verfolgen?

 
27.01.04 20:04
gibt es ein eigenes ESKIVANA-forum?
Antworten
r4lle:

ja gibt es

 
27.01.04 20:08
und von daher wirst du es nicht verfolgen können. Sorry, nur für ESKIVANER zugängig.

 

greetz

Antworten
patznjeschniki:

Verkauf FCFC o. T.

 
27.01.04 21:56
Antworten
mattb:

US-Experten

 
27.01.04 22:00
Hallo!

Dachte ich wende mich mal an die US-Experten. Was haltet ihr von Fidelity National Financial? Tolle Margen, seit Jahren konstant hohes Umsatzwachstum und ein sehr niedriges KGV (dieses Jahr wohl bei 7). Meinungen?
Antworten
der Tolle:

wie kommt man bei ESKIVANA rein? o. T.

 
28.01.04 01:07
Antworten
Auf neue Beiträge prüfen
Es gibt keine neuen Beiträge.

Seite: Übersicht Alle 1 2 3

Börsen-Forum - Gesamtforum - Antwort einfügen - zum ersten Beitrag springen

Neueste Beiträge aus dem SORRENTO NETWORKS CORP Forum

Wertung Antworten Thema Verfasser letzter Verfasser letzter Beitrag
  70 Zum US-Depot für ESKIVANA. Eskimato der Tolle 28.01.04 01:07

--button_text--